Vivitide’s Business Combination With Biosynth Carbosynth

McDermott Will & Emery represented Ampersand Capital Partners in the transaction.Ampersand Capital Partners, a healthcare-focused private equity fund, and KKR, a leading global investment firm, finalized an investment in…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here